# FDA recall D-1069-2020

> **Glaxosmithkline Consumer Healthcare Holdings** · Class II · drug recall initiated 2020-03-16.

## Product

Advil Liqui-Gel Mini 160+20+20 CT (e-commerce)  NDC # 0573-1715-59  SKU# F00573171559 (original lot # R53074)  Co-packaged Batch/Lot # 0198FR & 3188FRB

## Reason for recall

Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

## Distribution

Product was distributed throughout the United States, including Puerto Rico.

## Key facts

- **Recall number:** D-1069-2020
- **Recalling firm:** Glaxosmithkline Consumer Healthcare Holdings
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-03-16
- **Report date:** 2020-04-01
- **Termination date:** 2021-10-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Warren, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1069-2020

## Citation

> AI Analytics. FDA recall D-1069-2020. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1069-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*